KDM2B-IN-2

CAS No. 1965248-01-4

KDM2B-IN-2( —— )

Catalog No. M35115 CAS No. 1965248-01-4

KDM2B-IN-2 is a potent histone demethylase (kdm2b) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 154 In Stock
5MG 140 In Stock
10MG 217 In Stock
25MG 407 In Stock
50MG 594 In Stock
100MG 828 In Stock
200MG Get Quote In Stock
500MG 1702 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    KDM2B-IN-2
  • Note
    Research use only, not for human use.
  • Brief Description
    KDM2B-IN-2 is a potent histone demethylase (kdm2b) inhibitor.
  • Description
    KDM2B-IN-2, a potent histone demethylase (kdm2b) inhibitor with an IC50 of 0.021 μM in a KDM2B TR-FRET assay. KDM2B-IN-2 can be used for hyperproliferative diseases research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Histone Demethylase
  • Recptor
    Histone Demethylase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1965248-01-4
  • Formula Weight
    430.59
  • Molecular Formula
    C21H26N4O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 31.25 mg/mL (72.57 mM; ultrasonic and heat to 80°C)
  • SMILES
    O=S(=O)(N1CCN=C1N1CCN(CC1)C1CCC1)c1ccc(cc1)-c1ccsc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Brian K. Albrecht, et al. 4,5-dihydroimidazole derivatives and their use as histone demethylase (kdm2b) inhibitors. Patent WO2016112251A1.
molnova catalog
related products
  • KDM5-C49

    KDM5-C49 is a potent, selective KDM5 inhibitor with IC50 of 25, 30 and 59 nM for KDM5A, B and C, respectively.

  • GSK-2879552

    A potent, selective irreversible inhibitor of LSD1 with Ki app of 1.7 uM.

  • NCGC00244536

    NCGC00244536 is a potent KDM4B inhibitor (IC50: 10 nM).NCGC00244536 effectively inhibits AR-positive cell lines.